“IFF’s commitment to innovation ... This press release contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities ...

NEW YORK — IFF plans to discontinue certain ingredients within its Functional Ingredients portfolio after volume in that business declined more than 20% in the second quarter ended June 30.

In the fourth quarter of 2022, IFF’s top line fell 6% year-over-year (y-o-y) to $2.8 billion (missed consensus by $50 million) and its adjusted earnings per share were down 12% y-o-y to 97 cents ...